ReviewFrontiers in antibiotics2026
Current status of antimicrobial resistance in Indian healthcare system: combating antimicrobial resistance with precision medicine.
Review in Frontiers in antibiotics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Microbiological Profile of Pathogens Among Patients at a Tertiary Care Hospital in Mumbai, India.Cureus · 2026Article
- Impact of SGLT2 inhibitors on asymptomatic bacteriuria in T2DM: prevalence, pathogens and risk factors.Infection · 2026Article
- From Susceptible to Resistant: The Emergence of Carbapenemase-Producing Escherichia coli.Cureus · 2026Review
- Temporal Trends in Antibiotic Resistance of Klebsiella pneumoniae and Antibiotic Consumption: A Six-year Longitudinal Surveillance Study : Temporal Trends of Resistance and Consumption of Antibiotics to K. pneumoniae.Journal of epidemiology and global health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review provides a unique perspective by integrating antimicrobial resistance (AMR) data from Indian healthcare, with a particular emphasis on outpatient settings that are often overlooked in existing literature. Unlike previous reviews that primarily focus on hospital-acquired infections, this article explores the community dimension of AMR and its implications for public health. Furthermore, it introduces an innovative framework linking AMR mitigation strategies with precision medicine approaches, including pharmacogenomics, metabolomics, proteomics, and transcriptomics. By combining multi-omics insights with national surveillance data and stewardship initiatives, this review highlights the translational potential of personalized antimicrobial therapy tailored to the Indian healthcare ecosystem. This integrated perspective offers a novel direction for AMR research and policy, bridging the gap between genomic science and clinical application in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.